Primary |
Product Used For Unknown Indication |
29.4% |
Arthralgia |
13.4% |
Osteoarthritis |
7.0% |
Back Pain |
6.4% |
Arthritis |
5.9% |
Pain |
5.3% |
Pericardial Effusion |
5.3% |
Blood Pressure Increased |
3.7% |
Hypertension |
2.7% |
Supplementation Therapy |
2.7% |
Blood Pressure |
2.1% |
Pain In Extremity |
2.1% |
Rheumatoid Arthritis |
2.1% |
Ulcer |
2.1% |
Anxiety |
1.6% |
Blood Cholesterol Increased |
1.6% |
Bursitis |
1.6% |
Gout |
1.6% |
Musculoskeletal Pain |
1.6% |
Neck Pain |
1.6% |
|
Cardiac Tamponade |
14.5% |
Anaphylactic Reaction |
6.5% |
Incorrect Route Of Drug Administration |
6.5% |
Joint Swelling |
6.5% |
Pain |
6.5% |
Drug Rash With Eosinophilia And Systemic Symptoms |
4.8% |
Off Label Use |
4.8% |
Rash |
4.8% |
Renal Failure Acute |
4.8% |
Tubulointerstitial Nephritis |
4.8% |
Vomiting |
4.8% |
Wrong Drug Administered |
4.8% |
Accidental Exposure |
3.2% |
Application Site Pain |
3.2% |
Blister |
3.2% |
Dizziness |
3.2% |
Dyspnoea |
3.2% |
Expired Drug Administered |
3.2% |
Fatigue |
3.2% |
Flushing |
3.2% |
|
Secondary |
Arthralgia |
16.9% |
Back Pain |
10.8% |
Osteoarthritis |
9.6% |
Sciatica |
9.6% |
Blood Pressure Increased |
6.0% |
Pain |
6.0% |
Anticoagulant Therapy |
4.8% |
Fracture |
4.8% |
Ulcer |
4.8% |
Arthritis |
3.6% |
Abdominal Pain |
2.4% |
Blood Cholesterol |
2.4% |
Blood Pressure |
2.4% |
Groin Pain |
2.4% |
Hypertension |
2.4% |
Musculoskeletal Pain |
2.4% |
Product Used For Unknown Indication |
2.4% |
Prostatic Disorder |
2.4% |
Swelling |
2.4% |
Anxiety |
1.2% |
|
Off Label Use |
11.1% |
Chest Pain |
7.4% |
Completed Suicide |
7.4% |
Drug Ineffective |
7.4% |
Erythema |
7.4% |
International Normalised Ratio Increased |
7.4% |
Application Site Haematoma |
3.7% |
Cardio-respiratory Arrest |
3.7% |
Dizziness |
3.7% |
Drug Administered At Inappropriate Site |
3.7% |
Drug Effect Decreased |
3.7% |
Fatigue |
3.7% |
Gastrointestinal Disorder |
3.7% |
Incorrect Route Of Drug Administration |
3.7% |
Influenza |
3.7% |
Intentional Drug Misuse |
3.7% |
Maternal Exposure During Pregnancy |
3.7% |
Oedema Peripheral |
3.7% |
Rash |
3.7% |
Rash Macular |
3.7% |
|
Concomitant |
Product Used For Unknown Indication |
30.0% |
Rheumatoid Arthritis |
16.3% |
Drug Use For Unknown Indication |
9.0% |
Pain |
6.8% |
Osteoporosis |
4.9% |
Hypertension |
3.9% |
Arthritis |
3.2% |
Epilepsy |
3.2% |
Vitamin Supplementation |
2.9% |
Dyspepsia |
2.4% |
Nausea |
2.2% |
Supplementation Therapy |
2.2% |
Anxiety |
1.7% |
Depression |
1.7% |
Gastrooesophageal Reflux Disease |
1.7% |
Myalgia |
1.7% |
Psoriasis |
1.7% |
Back Pain |
1.5% |
Blood Cholesterol Increased |
1.5% |
Neuralgia |
1.5% |
|
Pyrexia |
9.5% |
Lymphoma |
7.1% |
Pain |
7.1% |
Pain In Extremity |
7.1% |
Pulmonary Embolism |
7.1% |
Retinal Detachment |
7.1% |
Death |
4.8% |
Drug Ineffective |
4.8% |
Epilepsy |
4.8% |
International Normalised Ratio Decreased |
4.8% |
International Normalised Ratio Increased |
4.8% |
Large Intestinal Haemorrhage |
4.8% |
Non-small Cell Lung Cancer Metastatic |
4.8% |
Painful Respiration |
4.8% |
Red Blood Cell Count Decreased |
4.8% |
Angioedema |
2.4% |
Bruxism |
2.4% |
Cerebellar Syndrome |
2.4% |
Cerebrovascular Accident |
2.4% |
Dermatitis Bullous |
2.4% |
|